methoxyhydroxyphenylglycol has been researched along with Childhood Torsion Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Messer, A; Riker, DK; Roth, RH | 1 |
| Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
| Mars, H | 1 |
| Lindvall, B; Olsson, JE | 1 |
| Chase, TN; Gordon, EK; Ng, LK | 1 |
5 other study(ies) available for methoxyhydroxyphenylglycol and Childhood Torsion Disease
| Article | Year |
|---|---|
Increased noradrenergic metabolism in the cerebellum of the mouse mutant dystonia musculorum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebellum; Corpus Striatum; Cyclic GMP; Dystonia Musculorum Deformans; Homovanillic Acid; Methoxyhydroxyphenylglycol; Mice; Mice, Mutant Strains; Norepinephrine; Protein Kinases; Tyrosine 3-Monooxygenase | 1981 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
Effect of supplemental ascorbic acid in a case of torsion dystonia.
Topics: Adult; Ascorbic Acid; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Epinephrine; Female; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Vanilmandelic Acid | 1976 |
Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
Topics: Dystonia Musculorum Deformans; Enkephalin, Methionine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Shy-Drager Syndrome; Somatostatin | 1990 |
Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Carbon Radioisotopes; Cerebrospinal Fluid; Child; Chromatography, Gas; Dihydroxyphenylalanine; Dopamine; Down Syndrome; Dystonia Musculorum Deformans; Female; Glycols; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Middle Aged; Norepinephrine; Parkinson Disease; Picolinic Acids; Probenecid; Serotonin; Spinal Cord Diseases; Time Factors | 1973 |